Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '5-fluorouracil' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 3795 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yekeler, H; Ozbakir, D
      Concerning the solvent effect in the tautomerism of uracil, 5-fluorouracil, and thymine by density-functional theory and ab initio calculations

      JOURNAL OF MOLECULAR MODELING
    2. Singh, RP; Goldberg, I; Mohsin, M
      The efficacy and safety of intraoperative and/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    3. Merriman, MB; Mora, JS; Beaumont, BW; Merrilees, MJ
      Effects of varying 5-fluorouracil exposure duration on Tenon's capsule fibroblasts

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    4. Cristofanilli, M; Pescosolido, N; Risuleo, G; Scarsella, G
      A murine cell culture model for post-trabeculectomy anfibrotic treatment: Induction of apoptosis by Cyclosporin

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    5. Deporte-Fety, R; Picot, M; Amiand, M; Moreau, A; Campion, L; Lanoe, D; Renee, N; Milano, G
      High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity

      JOURNAL OF CHROMATOGRAPHY B
    6. Van Kuilenburg, ABP; Stroomer, AEM; Peters, GJ; Van Gennip, AH
      Simultaneous determination of F-beta-alanine and beta-alanine in plasma and urine with dual-column reversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    7. Kuhara, T; Ohdoi, C; Ohse, M
      Simple gas chromatographic-mass spectrometric procedure for diagnosing pyrimidine degradation defects for prevention of severe anticancer side effects

      JOURNAL OF CHROMATOGRAPHY B
    8. Micoli, G; Turci, R; Arpellini, M; Minoia, C
      Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    9. Matheson, AJ; Nobel, S
      Management of colorectal cancer - Defining the role of raltitrexed

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    10. Ngan, SYK
      Optimising treatment for resectable rectal cancer - Is preoperative therapy beneficial?

      DRUGS & AGING
    11. Michel, JL; Has, C; Has, V
      Resurfacing CO2 laser treatment of linear verrucous epidermal nevus

      EUROPEAN JOURNAL OF DERMATOLOGY
    12. Paule, B; Saint, F
      Concomitant chemotherapy/radiotherapy in inoperable locally advanced bladder cancer

      PROGRES EN UROLOGIE
    13. Zhang, ZR; Luo, WZ; Nagai, T
      Hydrolysis kinetics and photolysis kinetics of N-1-retinoyl-5-fluorouracil

      STP PHARMA SCIENCES
    14. Correale, P; Sabatino, M; Cusi, MG; Micheli, L; Nencini, C; Pozzessere, D; Petrioli, R; Aquino, A; De Vecchis, L; Turriziani, M; Prete, SP; Sanguedolce, R; Rausa, L; Giorgi, G; Francini, G
      In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restrictedpeptides derived from human thymidylate synthase

      JOURNAL OF CHEMOTHERAPY
    15. Tominaga, T; Sano, M; Nishi, T; Sasaki, M; Yoshida, K; Kimura, M; Takashima, S; Asano, T; Yoshida, M; Fujiwara, J; Danno, M
      Postoperative chemoendocrine therapy for women with node-positive stage IIbreast cancer with combined cyclophosphamide, tamoxifen, and 1-hexylcarbamoyl-5-fluorouracil

      EUROPEAN JOURNAL OF SURGERY
    16. Lau, C; Mole, ML; Copeland, MF; Rogers, JM; Kavlock, RJ; Shuey, DL; Cameron, AM; Ellis, DH; Logsdon, TR; Merriman, J; Setzer, RW
      Toward a biologically based dose-response model for developmental toxicityof 5-fluorouracil in the rat: Acquisition of experimental data

      TOXICOLOGICAL SCIENCES
    17. Setzer, RW; Lau, C; Mole, ML; Copeland, MF; Rogers, JM; Kavlock, RJ
      Toward a biologically based dose-response model for developmental toxicityof 5-fluorouracil in the rat: A mathematical construct

      TOXICOLOGICAL SCIENCES
    18. Staib, L; Link, KH; Beger, HG
      Toxicity and effects of adjuvant therapy in colon cancer: Results of the german prospective, controlled randomized multicenter trial FOGT-1

      JOURNAL OF GASTROINTESTINAL SURGERY
    19. Bach, SP; Williamson, SE; Marshman, E; Kumar, S; O'Dwyer, ST; Potten, CS; Watson, AJM
      The antioxidant N-acetylcysteine increases 5-fluorouracil activity againstcolorectal cancer xenografts in nude mice

      JOURNAL OF GASTROINTESTINAL SURGERY
    20. Xu, HZ; Liu, SZ; Xia, XB; Huang, PG; Wang, PB; Wu, XY
      Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy

      JOURNAL OF REFRACTIVE SURGERY
    21. Yieh, FS; Lu, DW; Wang, HL; Chou, PI
      The use of autologous fibrinogen concentrate in treating ocular hypotony after glaucoma filtration surgery

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    22. Wolff, RA; Evans, DB; Gravel, DM; Lenzi, R; Pisters, PWT; Lee, JE; Janjan, NA; Charnsangavej, C; Abbruzzese, JL
      Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma

      CLINICAL CANCER RESEARCH
    23. Schwartz, G; Johnson, TR; Goetz, A; Burris, H; Smetzer, L; Lampkin, T; Sailstad, J; Hohneker, JA; Von Hoff, DD; Rowinsky, EK
      A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitorof thymidylate synthase, in patients with advanced solid malignancies

      CLINICAL CANCER RESEARCH
    24. Grem, JL; Danenberg, KD; Behan, K; Parr, A; Young, L; Danenberg, PV; Nguyen, D; Drake, J; Monks, A; Allegra, CJ
      Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the national cancer institute's anticancer drugscreen

      CLINICAL CANCER RESEARCH
    25. Fujimoto-Ouchi, K; Tanaka, Y; Tominaga, T
      Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models

      CLINICAL CANCER RESEARCH
    26. Damle, B; Ravandi, F; Kaul, S; Sonnichsen, D; Ferreira, I; Brooks, D; Stewart, D; Alberts, D; Pazdur, R
      Effect of food on the oral bioavailability of UFT and leucovorin in cancerpatients

      CLINICAL CANCER RESEARCH
    27. Komatsu, T; Yamazaki, H; Shimada, N; Nagayama, S; Kawaguchi, Y; Nakajima, M; Yokoi, T
      Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver

      CLINICAL CANCER RESEARCH
    28. Kim, NK; Park, JK; Lee, KY; Yang, WIK; Yun, SH; Sung, JS; Min, JS
      p53, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancer

      ANNALS OF SURGICAL ONCOLOGY
    29. Adam, R; Avisar, E; Ariche, A; Giachetti, S; Azoulay, D; Castaing, D; Kunstlinger, F; Levi, F; Bismuth, F
      Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases

      ANNALS OF SURGICAL ONCOLOGY
    30. Kuhn, JG
      Fluorouracil and the new oral fluorinated pyrimidines

      ANNALS OF PHARMACOTHERAPY
    31. Gilbar, PJ; Brodribb, TR
      Phenytoin and fluorouracil interaction

      ANNALS OF PHARMACOTHERAPY
    32. Khaw, PT
      Advances in glaucoma surgery: Evolution of antimetabolite adjunctive therapy

      JOURNAL OF GLAUCOMA
    33. Stamper, R
      Bilateral chronic hypotony following trabeculectomy with mitomycin-C

      JOURNAL OF GLAUCOMA
    34. Spaeth, GL; Mutlukan, E
      The use of antimetabolites with trabeculectomy: A critical appraisal

      JOURNAL OF GLAUCOMA
    35. Airoldi, M; De Stefani, A; Marchionatti, S; Pedani, F; Gabriele, P; Ragona, R; Cortesina, G; Bumma, C
      Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    36. Trudeau, C; Yuan, S; Galipeau, J; Benlimame, N; Alaoui-Jamali, MA; Batist, G
      A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells

      HUMAN GENE THERAPY
    37. Wang, SG; Chen, HL; Cai, Q; Bei, JZ
      Degradation and 5-fluorouracil release behavior in vitro of polycaprolactone/poly(ethylene oxide)/polylactide tri-component copolymer

      POLYMERS FOR ADVANCED TECHNOLOGIES
    38. Grothey, A; Schmoll, HJ
      New chemotherapy approaches in colorectal cancer

      CURRENT OPINION IN ONCOLOGY
    39. Catalano, V; Baldelli, AM; Giordani, P; Cascinu, S
      Molecular markers predictive of response to chemotherapy in gastrointestinal tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    40. Einmahl, S; Behar-Cohen, F; Tabatabay, C; Gurny, R
      Treatment of intralocular diseases with poly(ortho ester)-based drug delivery systems

      MACROMOLECULAR SYMPOSIA
    41. Mukai, M; Moriya, H; Himeno, S; Oida, Y; Mukohyama, S; Nishi, T; Nakasaki, H; Satoh, S; Makuuchi, H
      Efficacy of oral UFT plus leucovorin therapy for colon cancer with ovarianand multiple liver metastases: Report of two cases

      ONCOLOGY REPORTS
    42. Ianniello, GP; Orditura, M; Rossi, A; De Vita, F; Maiorino, L; Carrozza, F; Manzione, L; Catalano, G
      Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial

      ONCOLOGY REPORTS
    43. Sadahiro, S; Otani, Y; Oya, K; Ike, H; Shimada, H; Yamaguchi, S; Hiki, Y; Fujita, H; Mitomi, T
      Thymidine phosphorylase expression and effect of doxifluridine: A phase IIstudy

      ONCOLOGY REPORTS
    44. Ajiki, T; Habara, K; Kamigaki, T; Nakamura, T; Fujino, Y; Suzuki, Y; Takeyama, Y; Kuroda, Y; Nakamura, T
      Expression of thymidylate synthase in cancer of the ampulla of Vater

      ONCOLOGY REPORTS
    45. Oshima, T; Imada, T; Nagashima, Y; Cho, H; Shiozawa, M; Rino, Y; Takanashi, Y
      Role of nitric oxide in human gastric cancer cells treated with 5-fluorouracil

      ONCOLOGY REPORTS
    46. Ikeguchi, M; Hirooka, Y; Makino, M; Kaibara, N
      Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine

      ONCOLOGY REPORTS
    47. Lauerova, L; Dusek, L; Spurny, V; Simickova, M; Rovny, A; Rejthar, A; Kocak, I; Kovarik, J
      Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients

      ONCOLOGY REPORTS
    48. Yamamoto, K; Noda, K; Hatae, M; Kudo, T; Hasegawa, K; Nishimura, R; Honjo, H; Yajima, A; Sato, S; Mizutani, K; Yakushiji, M; Terashima, Y; Ochiai, K; Sasaki, H; Ozaki, M
      Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer

      ONCOLOGY REPORTS
    49. Ishii, R; Takiguchi, N; Oda, K; Koda, K; Miyazaki, M
      Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    50. Nakamura, T; Ohno, M; Tabuchi, Y; Kamigaki, T; Fujii, H; Yamagishi, H; Kuroda, Y
      Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III

      INTERNATIONAL JOURNAL OF ONCOLOGY
    51. Uchida, K; Hayashi, K; Kuramochi, H; Takasaki, K
      Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion

      INTERNATIONAL JOURNAL OF ONCOLOGY
    52. Yukimoto, K; Nakata, B; Muguruma, K; Yashiro, M; Ohira, M; Ishikawa, T; Hino, M; Hirakawa, K
      Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastriccancer cells with or without p53 mutation

      INTERNATIONAL JOURNAL OF ONCOLOGY
    53. Marsh, S; McKay, JA; Cassidy, J; McLeod, HL
      Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    54. Miyamoto, S; Ochiai, A; Boku, N; Ohtsu, A; Tahara, M; Yoshida, S; Okabe, H; Takechi, T; Fukushima, M
      Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa

      INTERNATIONAL JOURNAL OF ONCOLOGY
    55. Dusseau, C; Murray, GI; Keenan, RA; O'Kelly, T; Krokan, HE; McLeod, HL
      Analysis of uracil DNA glycosylase in human colorectal cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    56. Zagozdzon, R; Golab, J
      Immunomodulation by anticancer chemotherapy: More is not always better (review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    57. Lee, JH; Lee, JH; Kim, TW; Lee, KH; Kang, YK; Lee, JS; Kim, SH; Kim, HC; Yu, CS; Kim, JC; Kim, WK
      Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer

      JOURNAL OF KOREAN MEDICAL SCIENCE
    58. Chung-Faye, GA; Chen, MJ; Green, NK; Burton, A; Anderson, D; Mautner, V; Searle, PF; Kerr, DJ
      In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase

      GENE THERAPY
    59. Lee, SM; Chung, ID; Lee, NJ; Ha, CS; Lee, CH; Cho, WJ
      Synthesis and antitumour and antiangiogenesis activity of polymers containing methacryloyl-2-oxy-1,2,3-propane tricarboxylic acid

      POLYMER INTERNATIONAL
    60. Namer, M; Soler-Michel, P; Turpin, F; Chinet-Charrot, P; de Gislain, C; Pouillart, P; Delozier, T; Luporsi, E; Etienne, PL; Schraub, S; Eymard, JC; Serin, D; Ganem, G; Calais, G; Maillart, P; Colin, P; Trillet-Lenoir, V; Prevost, G; Tigaud, D; Clavere, P; Marti, P; Romieu, C; Wendling, JL
      Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

      EUROPEAN JOURNAL OF CANCER
    61. Witkamp, AJ; de Bree, E; Kaag, MM; Boot, H; Beijnen, JH; van Slooten, GW; van Coevorden, F; Zoetmulder, FAN
      Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin

      EUROPEAN JOURNAL OF CANCER
    62. Cunningham, D; James, RD
      Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    63. Mizutani, Y; Wada, H; Fukushima, M; Yoshida, O; Ukimura, O; Kawauchi, A; Miki, T
      The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

      EUROPEAN JOURNAL OF CANCER
    64. Alonso, V; Escudero, P; Zorrilla, M; Isla, MD; Herrero, A; Mayordomo, JI; Martinez-Trufero, J; Saenz, A; Tres, A; Anton, A
      Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    65. Cavaletti, G; Tredici, G; Petruccioli, MG; Donde, E; Tredici, P; Marmiroli, P; Minoia, C; Ronchi, A; Bayssas, M; Etienne, GG
      Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat

      EUROPEAN JOURNAL OF CANCER
    66. Valentini, V; Doglietto, GB; Morganti, AG; Turriziani, A; Smaniotto, D; De Santis, M; Ratto, C; Sofo, L; Cellini, N
      Preoperative chemoradiation with raltitrexed ('Tomudex') for T2/N+ and T3/N+ rectal cancers: a phase I study

      EUROPEAN JOURNAL OF CANCER
    67. Fukushima, M; Fujioka, A; Uchida, J; Nakagawa, F; Takechi, T
      Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo

      EUROPEAN JOURNAL OF CANCER
    68. Llovet, JM; Ruff, P; Tassopoulos, N; Castells, L; Bruix, J; El-Hariry, I; Peachey, M
      A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma

      EUROPEAN JOURNAL OF CANCER
    69. Monfardini, S
      Medical oncology

      EUROPEAN JOURNAL OF CANCER
    70. Johnston, PG; Kaye, S
      Capecitabine: a novel agent for the treatment of solid tumors

      ANTI-CANCER DRUGS
    71. Takeda, Y; Yoshizaki, I; Nonaka, Y; Yanagie, H; Matsuzawa, A; Eriguchi, M
      Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo

      ANTI-CANCER DRUGS
    72. Caponigro, F; Avallone, A; Budillon, A; Comella, P; Comella, G
      Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy

      ANTI-CANCER DRUGS
    73. Polee, MB; Kok, TC; Siersema, PD; Tilanus, NW; Splinter, TAW; Stoter, G; Van der Gaast, A
      Phase II study of the combination cisplatin, etoposide, 5-fluorouracil andfolinic acid in patients with advanced squamous cell carcinoma of the esophagus

      ANTI-CANCER DRUGS
    74. Saif, MW; Wilson, RH; Harold, N; Keith, B; Dougherty, DS; Grem, JL
      Peripheral neuropathy associated with weekly oval 5-fluorouvacil, leucovorin and eniluracil

      ANTI-CANCER DRUGS
    75. Chen, JS; Lin, YC; Jan, YY; Liau, CT
      Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas

      ANTI-CANCER DRUGS
    76. Posner, MR
      Docetaxel in squamous cell cancer of the head and neck

      ANTI-CANCER DRUGS
    77. Edmunds, B; Thompson, JR; Salmon, JF; Wormald, RP
      The national survey of trabeculectomy. II. Variations in operative technique and outcome

      EYE
    78. Anand, N; Mielke, C; Dawda, VK
      Trabeculectomy outcomes in advanced glaucoma in Nigeria

      EYE
    79. Sung, VCT; Butler, TKH; Vernon, SA
      Non-enhanced trabeculectomy by non-glaucoma specialists: are results related to risk factors for failure?

      EYE
    80. Picht, G; Mutsch, Y; Grehn, F
      Postoperative complications and therapeutic consequences after trabeculectomy

      OPHTHALMOLOGE
    81. Nakamura, H; Sekiguchi, H; Akiyama, S; Hamada, H; Fujiwara, M; Kasai, Y; Ito, K; Nakao, A
      Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene increases the sensitivity of esophageal cancer cells to 5-fluorouracil

      SURGERY TODAY
    82. Nozawa, H; Sekikawa, T; Tsukui, H; Kina, S; Kawahara, T; Ono, K; Kishida, Y; Yakumaru, K; Kagami, H
      Gastric cancer with Virchow's and multiple lung metastases showing a remarkable response to preoperative chemotherapy: Report of a case

      SURGERY TODAY
    83. Shimizu, T; Shimada, H; Ochiai, T; Hamada, H
      Enhanced growth suppression in esophageal carcinoma cells using adenovirus-mediated fusion gene transfer (uracil phosphoribosyl transferase and herpes simplex virus thymidine kinase)

      CANCER GENE THERAPY
    84. D'Hondt, L; Carlson, J; Benoit, B; Reilly, J; Grimaldi, C; Wuu, J; Lambert, JF; Dooner, MS; Quesenberry, PJ
      Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    85. Skovsgaard, T; Davidson, NGP; Piccart, MJ; Richel, DJ; Bonneterre, J; Cirkel, DT; Barton, CM; Knight, S
      A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer

      ANNALS OF ONCOLOGY
    86. Di Paolo, A; Danesi, R; Falcone, A; Cionini, L; Vannozzi, F; Masi, G; Allegrini, G; Mini, E; Bocci, G; Conte, PF; Del Tacca, M
      Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients

      ANNALS OF ONCOLOGY
    87. Glimelius, B
      Chemoradiotherapy for rectal cancer - is there an optimal combination?

      ANNALS OF ONCOLOGY
    88. Ramanathan, RK; Cnaan, A; Hahn, RG; Carbone, PP; Haller, DG
      Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

      ANNALS OF ONCOLOGY
    89. Knowling, M; Browman, G; Siu, L; Khoo, K; Cooke, A; Tannock, I; Klaassen, D; Cripps, C; Goss, G; Matthews, S; Clarke, R; Seymour, L
      A National Cancer Institute of Canada Clinical Trials Group phase II studyof eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer

      ANNALS OF ONCOLOGY
    90. Hussain, SA; Moffitt, DD; Glaholm, JG; Peake, D; Wallace, DMA; James, ND
      A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer

      ANNALS OF ONCOLOGY
    91. Gebbia, V; Testa, A; Borsellino, N; Ferrera, P; Tirrito, M; Palmeri, S
      Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen

      ANNALS OF ONCOLOGY
    92. Villalona-Calero, MA; Blum, JL; Jones, SE; Diab, S; Elledge, R; Khoury, P; Von Hoff, D; Kraynak, M; Moczygemba, J; Kromelis, P; Griffin, T; Rowinsky, EK
      A phase I and pharmacologic study of capecitabine and paclitaxel in breastcancer patients

      ANNALS OF ONCOLOGY
    93. Rosati, G; Rossi, A; Tucci, A; Pizza, C; Manzione, L
      Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer

      ANNALS OF ONCOLOGY
    94. Louvet, C; Andre, T; Hammel, P; Selle, F; Landi, B; Cattan, S; Fonck, M; Flesch, M; Colin, P; Balosso, J; Ruszniewski, P; de Gramont, A
      Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM)

      ANNALS OF ONCOLOGY
    95. Sanz-Altamira, PM; O'Reilly, E; Stuart, KE; Raeburn, L; Steger, C; Kemeny, NE; Saltz, LB
      A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma

      ANNALS OF ONCOLOGY
    96. Martoni, A; Mini, E; Pinto, C; Nobili, S; Gentile, AL; Dentico, P; Angelelli, B; Scicolone, S; Piana, E; Mazzei, T
      Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma

      ANNALS OF ONCOLOGY
    97. Saghatchian, M; Fizazi, K; Borel, C; Ducreux, M; Ruffie, P; Le Chevalier, T; Theodore, C
      Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

      ANNALS OF ONCOLOGY
    98. Volk, J; Reinke, F; van Kuilenburg, ABP; van Gennip, AH; Schlichting, C; Ganser, A; Schoffski, P
      Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer

      ANNALS OF ONCOLOGY
    99. Huinink, DT; Tesselaar, MET; de Jong, RBB; Verschuur, HP; Keizer, HJ
      A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex (R)) in the treatment of patients with locally advanced ormetastatic squamous cell carcinoma of the head and neck

      ANNALS OF ONCOLOGY
    100. Peiffert, D; Giovannini, M; Ducreux, M; Michel, P; Francois, E; Lemanski, C; Mirabel, X; Cvitkovic, F; Luporsi, E; Conroy, T; Gerard, JP
      High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

      ANNALS OF ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 16:21:46